Screening is the process of looking for cancer in people who have no symptoms of the disease. If colorectal cancer screening reveals a problem, diagnosis and treatment can occur promptly.Colorectal canceris generally more treatable when it is found early, before it has ha...
METHODS FOR SCREENING 筛查方法 • Fecal occult blood test 大便潜血检查 Colon cancer can cause a small amount of occult (not visible) bleeding. Testing for this occult blood involves placing a small sample of feces on a card and then adding a chemical solution. If the result indicates the p...
The gold standard screening test for cancer in your colon or rectum, colorectal cancer, is a colonoscopy. This is done at a doctor's office under sedation, after a day of preparation that involvesfastingand clearing out your bowels. But there are alternatives: tests you take at home by coll...
If the test is positive, the next step is a diagnostic colonoscopy. A thin tube with a tiny camera is passed through the large intestine and growths can be removed and checked for cancer. When this is done for screening and precancerous polyps are removed, it can prevent cancer, not jus...
cancer which can last several years,giving a great opportunity to the scientific community for its prevention by screening programs that can be done with invasive and non-invasive tests.In this issue,Lopes et al show us an excellent review of screening,its options,its advantages and disadvantages...
METHODS FOR SCREENING 筛查方法 • Fecal occult blood test 大便潜血检查 Colon cancer can cause a small amount of occult (not visible) bleeding. Testing for this occult blood involves placing a small sample of feces on a card and then adding a chemi...
Cologuard® is a noninvasive at-home colon cancer screening test for adults 45+ at average risk. See risk info and talk to your provider. Rx only.
Cologuard® is a noninvasive at-home colon cancer screening test for adults 45+ at average risk. See risk info and talk to your provider. Rx only.
METHODS FOR SCREENING 筛查方法 • Fecal occult blood test 大便潜血检查 Colon cancer can cause a small amount of occult (not visible) bleeding. Testing for this occult blood involves placing a small sample of feces on a card and then adding a chemical solution. If the result indicates the ...
In 2016, the FDA approved the first blood-based colorectal cancer screening test, Epi proColon. This is a qualitative in vitro assay for detecting methylated Septin9 DNA, which has been associated with the occurrence of colorectal cancer, in plasma obtained from whole-blood specimens. It is indi...